Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1

Conditions

Carcinoma, Renal Cell 7Carcinoma 2Neoplasms 1Lymphoma, Mantle-Cell 1Kidney Neoplasms 1

Interventions

temsirolimus 2Sunitinib 2Sorafenib 2Axitinib 2sonidegib 1niraparib 1lenvatinib 1gadolinium ethoxybenzyl DTPA 1donafenib 1Transurethral Resection of Prostate 1Therapeutics 1Phlebotomy 1Palliative Care 1Mitomycin 1Methylation 1Maintenance 1Interviews as Topic 1Hyperthermic Intraperitoneal Chemotherapy 1HhAntag691 1Hepatectomy 1Fatty Acids, Omega-6 1Endoscopy 1Cetuximab 1Breath Tests 1Blood Specimen Collection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Carcinoma × Axitinib × Clear all
NCT00700258 2024-09-23

STAR-TOR

Pfizer

Completed
1,520 enrolled 24 charts
Lymphoid

Carcinoma, Lymphoma, Mantle-Cell

NCT04033991 2023-04-06

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Pfizer

Completed
684 enrolled 20 charts
Tumor-Agnostic

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡